Top of the morning to you, and a fine one it is. Sunny skies and cool breezes are enveloping the Pharmalot campus, where the short person is, once again, hovering over a laptop and the official mascot is happily snoozing in a corner. All of which means we are able to focus on the tasks at hand. First up is brewing another cup of stimulation. Our choice today is cinnamon dolce. Feel free to join us. Meanwhile, here are a few items of interest to get you going. We hope today is productive and enjoyable. Meanwhile, stay in touch and stay safe — wear a mask. …
Food and Drug Administration Commissioner Stephen Hahn defended his agency’s vetting process for the Pfizer (PFE) Covid-19 vaccine, saying a thorough and meticulous review is needed to assure a skeptical public of safety and effectiveness, The Wall Street Journal tells us. Hahn maintained the agency has had 150 people working days, nights and weekends in parallel teams to review the test data submitted. His comments came on the day that U.K. regulators cleared the Pfizer vaccine for general distribution.
A cynic might observe (although not this writer) that sending the boss to HHS has paid off handsomely for Lilly? Those two purchases seem to roughly total over $1.S Billion USD.
Comments are closed.